or
forgot password
  • cancer clinical trials in stanford, CA

  • Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
    Stanford Univ School of Medicine
    Stanford, California 94305
    HIV Infections
    Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
    Stanford Univ Med Ctr

    Trial Locations
    Stanford Univ Med Ctr
    San Mateo AIDS Program / Stanford Univ
    Mycobacterium Avium-intracellulare Infection, HIV Infections
    A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
    Stanford Univ Med Ctr

    Trial Locations
    Stanford Univ Med Ctr
    San Mateo AIDS Program / Stanford Univ
    HIV Infections
    A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
    San Mateo AIDS Program / Stanford Univ
    Stanford, California 943055107
    HIV Infections
    A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
    Stanford Univ Med Ctr

    Trial Locations
    Stanford Univ Med Ctr
    San Mateo AIDS Program / Stanford Univ
    HIV Infections
    A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients
    Stanford Univ Med Ctr

    Trial Locations
    Stanford Univ Med Ctr
    San Mateo AIDS Program / Stanford Univ
    HIV Infections
    A Study of Patients With AIDS Syndrome
    Stanford Univ Med Ctr

    Trial Locations
    Stanford Univ Med Ctr
    San Mateo AIDS Program / Stanford Univ
    Sarcoma, Kaposi, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Stanford University
    Stanford, California 94305
    Brain and Central Nervous System Tumors
    Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Cervical Cancer, Vaginal Cancer
    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Ovarian Cancer
    S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
    Stanford University Medical Center
    Stanford, California 94305-5408
    Colorectal Cancer
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Talc in Treating Patients With Malignant Pleural Effusion
    Stanford University
    Stanford, California 94305
    Metastatic Cancer
    Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Stanford University
    Stanford, California 94305
    Metastatic Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma
    Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia
    Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Leukemia, Lymphoma
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer
    Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Breast Cancer
    Group Therapy Compared With Educational Materials in Patients With Prostate Cancer
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Stanford University
    Stanford, California 94305
    Breast Cancer
    Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia
    Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer
    Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain and Central Nervous System Tumors
    Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Sarcoma
    Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia, Lymphoma, Myelodysplastic Syndromes
    Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer
    Methylphenidate in Treating Patients With Melanoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Thymoma and Thymic Carcinoma
    Ifosfamide in Treating Patients With Meningeal Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Rhabdomyosarcoma, Adult Malignant Meningioma, Adult Brain Malignant Hemangiopericytoma
    Brachytherapy in Treating Patients With Prostate Cancer
    Stanford University
    Stanford, California 94305
    Prostate Cancer
    Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Melanoma (Skin)
    Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lung Cancer
    O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Breast Cancer
    Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Leukemia
    Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Head and Neck Cancer
    Rituximab in Treating Patients With Hodgkin's Lymphoma
    Stanford University Medical Center

    Trial Locations
    Stanford University Medical Center
    Stanford University School of Medicine
    Lymphoma, Hodgkin Lymphoma (Category)
    Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lung Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Stanford Cancer Center at Stanford University Medical Center
    Stanford, California 94305
    Breast Cancer